Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy
- PMID: 15254046
- DOI: 10.1200/JCO.2004.05.158
Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy
Abstract
Purpose: The incidence of prostate cancer is frequent, occurring in almost one-third of men older than 45 years. Only a fraction of the cases reach the stages displaying clinical significance. Despite the advances in our understanding of prostate carcinogenesis and disease progression, our knowledge of this disease is still fragmented. Identification of the genes and patterns of gene expression will provide a more cohesive picture of prostate cancer biology.
Patients and methods: In this study, we performed a comprehensive gene expression analysis on 152 human samples including prostate cancer tissues, prostate tissues adjacent to tumor, and organ donor prostate tissues, obtained from men of various ages, using the Affymetrix (Santa Clara, CA) U95a, U95b, and U95c chip sets (37,777 genes and expression sequence tags).
Results: Our results confirm an alteration of gene expression in prostate cancer when comparing with nontumor adjacent prostate tissues. However, our study also indicates that the gene expression pattern in tissues adjacent to cancer is so substantially altered that it resembles a cancer field effect.
Conclusion: We also found that gene expression patterns can be used to predict the aggressiveness of prostate cancer using a novel model.
Similar articles
-
Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.J Urol. 2005 Jan;173(1):10-20. doi: 10.1097/01.ju.0000141582.15218.10. J Urol. 2005. PMID: 15592017 Review.
-
Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.Prostate. 2008 Oct 1;68(14):1496-509. doi: 10.1002/pros.20756. Prostate. 2008. PMID: 18366025
-
Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.Jpn J Clin Oncol. 2004 Jul;34(7):414-9. doi: 10.1093/jjco/hyh073. Jpn J Clin Oncol. 2004. PMID: 15342669
-
Methylation of the ASC gene promoter is associated with aggressive prostate cancer.Prostate. 2006 May 15;66(7):687-95. doi: 10.1002/pros.20371. Prostate. 2006. PMID: 16425203
-
Alterations of p53 are common in early stage prostate cancer.Can J Urol. 2003 Aug;10(4):1924-33. Can J Urol. 2003. PMID: 14503938 Review.
Cited by
-
ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.Oncol Rep. 2013 Jan;29(1):306-14. doi: 10.3892/or.2012.2079. Epub 2012 Oct 16. Oncol Rep. 2013. PMID: 23076342 Free PMC article.
-
Multi-Omics Analysis of Primary Prostate Cancer Datasets Reveals Novel Biomarkers.Biochem Genet. 2024 Aug 7. doi: 10.1007/s10528-024-10899-y. Online ahead of print. Biochem Genet. 2024. PMID: 39112820
-
EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent.Science. 2012 Dec 14;338(6113):1465-9. doi: 10.1126/science.1227604. Science. 2012. PMID: 23239736 Free PMC article.
-
Metallothionein 1 h tumour suppressor activity in prostate cancer is mediated by euchromatin methyltransferase 1.J Pathol. 2013 Jun;230(2):184-93. doi: 10.1002/path.4169. J Pathol. 2013. PMID: 23355073 Free PMC article.
-
A transcriptional repressor co-regulatory network governing androgen response in prostate cancers.EMBO J. 2012 Jun 13;31(12):2810-23. doi: 10.1038/emboj.2012.112. Epub 2012 Apr 24. EMBO J. 2012. PMID: 22531786 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases